ATE315228T1 - Immunoassay zum bestimmen von bnp - Google Patents

Immunoassay zum bestimmen von bnp

Info

Publication number
ATE315228T1
ATE315228T1 AT98941797T AT98941797T ATE315228T1 AT E315228 T1 ATE315228 T1 AT E315228T1 AT 98941797 T AT98941797 T AT 98941797T AT 98941797 T AT98941797 T AT 98941797T AT E315228 T1 ATE315228 T1 AT E315228T1
Authority
AT
Austria
Prior art keywords
bnp
immunoassay
mammalian
gamma
alpha
Prior art date
Application number
AT98941797T
Other languages
English (en)
Inventor
Hidehisa Asada
Hiroyuki Shimizu
Kazuaki Endo
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315228(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE315228T1 publication Critical patent/ATE315228T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98941797T 1997-09-11 1998-09-10 Immunoassay zum bestimmen von bnp ATE315228T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11

Publications (1)

Publication Number Publication Date
ATE315228T1 true ATE315228T1 (de) 2006-02-15

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941797T ATE315228T1 (de) 1997-09-11 1998-09-10 Immunoassay zum bestimmen von bnp

Country Status (13)

Country Link
US (1) US6828107B2 (de)
EP (1) EP1016867B1 (de)
JP (1) JP3516655B2 (de)
KR (1) KR100563358B1 (de)
CN (1) CN1161609C (de)
AT (1) ATE315228T1 (de)
AU (1) AU731858B2 (de)
CA (1) CA2304263C (de)
DE (1) DE69833118T2 (de)
DK (1) DK1016867T3 (de)
ES (1) ES2256952T3 (de)
NO (1) NO325020B1 (de)
WO (1) WO1999013331A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
US7670769B2 (en) 2002-05-09 2010-03-02 The Brigham And Women's Hospital, Inc. IL1RL-1 as a cardiovascular disease marker and therapeutic target
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
EP2256132B1 (de) * 2003-05-12 2015-04-01 Roche Diagnostics GmbH Verfahren zum Nachweis von ProBNP mit einem monoklonalen Antikörper
DE602004029680D1 (de) 2003-06-20 2010-12-02 Mayo Foundation Isoformen von gehirn-natriuretischem peptid
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ，インク． 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
EP2267456A3 (de) * 2004-03-19 2011-08-17 Biomedica Medizinprodukte GmbH & Co KG Prognoseverfahren für kongestives Herzversagen
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
WO2006031583A2 (en) * 2004-09-09 2006-03-23 Biosite Incorporated Methods and compositions for measuring canine bnp and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
CA2629438C (en) 2005-11-09 2014-02-25 Abbott Laboratories Human bnp immunospecific antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
PL2386860T4 (pl) 2006-04-24 2015-09-30 Critical Care Diagnostics Inc Przewidywanie śmiertelności i wykrywanie poważnej choroby
PT2021796E (pt) * 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnóstico de doença cardiovascular
EP2054433B1 (de) 2006-08-08 2017-12-13 Mayo Foundation For Medical Education And Research Diuretische und natriuretische polypeptide
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
US20080280377A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
SI2269063T1 (sl) 2008-04-18 2014-01-31 Critical Care Diagnostics, Inc. Napoved tveganja večjih neugodnih pojavov na srcu
WO2009149108A1 (en) 2008-06-02 2009-12-10 Loma Vista Medical, Inc. Inflatable medical devices
WO2010077654A1 (en) * 2008-12-08 2010-07-08 Biosite Incorporated Combined natriuretic peptide assays
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
US9592119B2 (en) 2010-07-13 2017-03-14 C.R. Bard, Inc. Inflatable medical devices
AU2011285694B2 (en) 2010-08-04 2014-12-18 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
EP2715353B1 (de) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. Nachweis von abbauprodukten von felinem nt-probnp
KR20140059249A (ko) 2011-08-30 2014-05-15 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 나트륨이뇨 폴리펩티드
WO2013103896A1 (en) 2012-01-06 2013-07-11 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
HK1212057A1 (en) 2012-08-21 2016-06-03 重症监护诊断股份有限公司 Multimarker risk stratification
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 ｈＢＮＰを認識するモノクローナル抗体および該抗体を用いるｈＢＮＰの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
CA2304263A1 (en) 1999-03-18
DE69833118T2 (de) 2006-08-31
CN1278919A (zh) 2001-01-03
WO1999013331A1 (en) 1999-03-18
EP1016867B1 (de) 2006-01-04
EP1016867A4 (de) 2004-11-17
KR20010023853A (ko) 2001-03-26
NO325020B1 (no) 2008-01-14
CN1161609C (zh) 2004-08-11
US6828107B2 (en) 2004-12-07
US20030157596A1 (en) 2003-08-21
KR100563358B1 (ko) 2006-03-22
CA2304263C (en) 2008-07-29
ES2256952T3 (es) 2006-07-16
AU9001098A (en) 1999-03-29
EP1016867A1 (de) 2000-07-05
AU731858B2 (en) 2001-04-05
NO20001273L (no) 2000-05-10
JP3516655B2 (ja) 2004-04-05
NO20001273D0 (no) 2000-03-10
DE69833118D1 (de) 2006-03-30
DK1016867T3 (da) 2006-05-22

Similar Documents

Publication Publication Date Title
ATE315228T1 (de) Immunoassay zum bestimmen von bnp
DE69902676D1 (de) Assay unter verwendung von porositätsverminderung zur verhinderung von migration
CA2198958A1 (en) Method for amplification of the response signal in a sandwich immunoassay
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
FI954029A0 (fi) Kemiluminesoiva reagenssi ja analyysimenetelmä, jossa käytetään substituoitua asetanilidia valon muodostukseen
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
EP0113075A3 (de) Tragbares Immunoassay-Reaktionssystem, Verfahren zur Diagnose durch eine Immunbestimmung und Sonde oder Träger zur Durchführung des Verfahrens
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
ES2023868B3 (es) Procedimiento de determinacion inmunometrico
EP1072888A3 (de) Immunoassay-Verfahren und -Reagens für HIV-1p24-Antigen
WO1994025617A3 (de) Monoklonale antikörper gegen ck-mb
ATE153134T1 (de) Immunoassayverfahren unter anwendung photothermischer strahlablenkungsspektroskopie
AU657719B2 (en) Methods for determination of an analyte
DE59109139D1 (de) Immunologischer Nachweis von Metolachlor
ES2054686T3 (es) Equipo de inmunoensayo.
DE59606685D1 (de) Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
KR860007545A (ko) 인체 프로릴 4-히드록시라아제의 정량 방법
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
DE69727975D1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper, immunoassays und detektion von kürzfristigem alkoholkonsum
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
JPS5386014A (en) Quantitative analysis of antigen and antibody
AU7943091A (en) Immunological detection methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties